Skip to content

US Facilities Engineered for API, HPAPI, and Scale-Up Excellence

Wilmington PharmaTech operates FDA-inspected facilities in Delaware on a former DuPont/Merck site with a long history of chemical manufacturing excellence.

Our campus integrates discovery and development laboratories and GMP capabilities (including kilo-, pilot-, and commercial-scale manufacturing with dedicated HPAPI suites) and analytical laboratories within a single footprint. This co-location supports efficient collaboration, rapid decision-making, and smoother transitions from development into manufacturing. The site also includes zoned/permitted space for future expansion, enabling Wilmington PharmaTech to grow alongside client programs.

Get in Touch
Integrated Chemistry

A Delaware-Based Campus with Adaptable, Integrated Labs and Manufacturing Suites

Located on a former DuPont/Merck site, Wilmington PharmaTech’s campus reflects decades of chemical manufacturing heritage combined with ongoing investment in modern laboratories, containment infrastructure, and quality systems. Wilmington PharmaTech’s facilities bring discovery, development, analytical, and manufacturing functions together within a single, integrated campus.

  • Four GMP suites with reactors up to 300 L

  • 400-3000 L reactor bays for IND-enabling through small-scale commercial API

  • Purpose-built for OEB 5 containment; trained staff and full infrastructure in place for HPAPI runs

  • Method development, validation, release testing, ICH stability, impurity identification, and reference standards support

  • 18 refrigerators/freezers and over 5,000 cubic feet of ICH/photo-stability chambers for GMP materials and studies

This co-location allows scientific and operational teams to work closely, share context, and make decisions quickly as programs evolve. Development processes move into manufacturing with full continuity, reducing the friction and risk often associated with site transfers or fragmented vendor models.

Hear our Managing Director lay out our manufacturing expansion plans in a CPHI interview

with flexibility

Capacity, Scalability, and Future Growth

Wilmington PharmaTech’s campus is designed not only to meet current program needs but also to support future growth.

Existing infrastructure supports kilo-scale through pilot-scale manufacturing and commercial production for complex small molecule APIs. Importantly, the site includes significant permitted space within our 54-acre campus that enables expansion of manufacturing, HPAPI capacity, and analytical capabilities in alignment with client pipelines and long term supply requirements.

This flexibility allows Wilmington PharmaTech to invest proactively while maintaining stability for ongoing programs.

Learn More About Where We Are Going
with Quality

Built for Regulatory Confidence

Facility design and operation at Wilmington PharmaTech are grounded in regulatory readiness.

Manufacturing and laboratory areas operate within established quality systems that support data integrity, traceability, and compliance. The site has a long history of FDA inspections and regulatory engagement, reinforcing Wilmington PharmaTech’s ability to support critical clinical and commercial programs.

This regulatory foundation provides clients with confidence when planning long-term manufacturing partnerships.

Our Resources

SEND AN INQUIRY

We’re Ready to Start

Looking to connect? We welcome the opportunity to discuss your needs and questions.

Get in Touch